You are here: Home News PhinC makes buyback of EMF Consulting official

PhinC makes buyback of EMF Consulting official

Evry (Essone), March 6, 2013 Today, PhinC Development, a company specializing in pharmacometrics and biotechnology companies support for the development of drugs, makes the buyback of the company EMF Consulting official.

EMF Consulting is a pioneering company in the field of pharmacometrics and drug development services. The company was founded in 2000 by Eliane Fuseau, an expert in applied Modelling and Simulation in clinical research and greatly involved in developing this discipline in Europe.

This acquisition is intended as a partnership formed between the two entities. It will allow PhinC Development to extend its business, particularly in applied Modelling and Simulation in phase III of clinical development, and EMF to continue its consulting, analysis and training activities.

PhinC and EMF will gradually combine their respective skills. In addition to their shared values with regard to scientific standards and integrity, it is important to keep both companies' assets; PhinC's close relationship with biopharmaceuticals companies and EMF's recognition amongst international pharmaceutical companies.

Bernard Orlandini, Managing Director of PhinC Development, explains: "Thanks to the acquisition of EMF Consulting, we have the unique opportunity to consolidate our position in Europe and broaden the opportunities of working with the 'big pharmas'. This will contribute to achieving our strategic development goals more quickly. "

Eliane Fuseau, founder of EMF, looks forward to "sharing skills and knowledge with the PhinC Development team, thereby ensuring the longevity of EMF Consulting's activities".

For more information, visit EMF Consulting new website http://www.emf-consulting.com/ .